跳至主要内容
临床试验/NCT01552486
NCT01552486Unknown不适用

Biology and Clinical Outcomes of Chiropractic Spinal Manipulative Therapy in the Treatment of Patients With Acute Inflammatory Radiculopathy Secondary to Lumbar Disc Herniation: a Pilot Study

Vancouver General Hospital2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2012年6月最近更新:
适应症

试验速览

阶段
不适用
入组人数
40
试验地点
2
主要终点
Rate of recruitment of eligible patients

研究概览

简要总结

Comparisons of surgical and non-operative treatment of patients with acute sciatica secondary to lumbar intervertebral disc herniation (AS/LDH) have shown no appreciable difference in outcome. The composition of the non-operative treatment of this patient population remains poorly defined. Spinal manipulative therapy (SMT) has demonstrated value in the treatment of AS/LDH. Recent preliminary studies suggest that SMT provides therapeutic benefit through the modulation of in vivo inflammatory mediators. This feasibility study will define the key experimental variables required to conduct a large multicentre study that will clarify the biological and clinical outcomes of SMT in the treatment of patients with AS/LDH.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
19 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • chief complaint of sciatica rather than lower back pain
  • pain of up to 6 months' duration
  • a McCulloch criteria score of 5/5 (two clinical symptoms and two clinical signs of sciatica, and diagnostic imaging confirming the presence of a herniated nucleus pulposus contacting a spinal nerve root at the appropriate level)
  • fluency in spoken and written English to ensure subjects understand the content of questionnaires and consent

排除标准

  • progressive neurological deficit
  • spinal fracture
  • spinal tumor
  • spinal infection
  • spinal nerve root motor score of less than 4/5
  • spinal stenosis that is not attributable to a herniated disc
  • any other significant spinal ailment or local or generalized co-morbidity ailment that could affect outcomes independently of SMT ( e.g. seronegative spondyloarthropathy, malignancy).

结局指标

主要结局

Rate of recruitment of eligible patients

时间窗: The number of patients recruited per week for 19 months

次要结局

  • mRDQ and VAS(Change from baseline and 24 weeks post-surgery and/or post-CSMT)
  • Total mRNA levels (isolated from disc tissue and disc / periradicular lavage samples) of interleukins 1,10 and 11, MIP-1 beta TNF alpha, and chemotactic protein alpha.(Specimens will be harvested an average of 6 weeks post-randomization)
  • mRMQ and VAS(Change from baseline and 12 weeks post-surgery and/or post-CSMT)
  • Cytokine and cytokine mRNA levels in serum.(Change from baseline cytokine and mRNA levels in serum and 24 weeks post-surgery and/or post-CSMT)
  • Cytokine and cytokine mRNA levels in serum(Change from baseline cytokine and mRNA levels in serum and 12 weeks post-surgery and/or post-CSMT)
  • Modified Roland Disability Questionnaire (mRDQ) score and Visual Analogue Scale (VAS) pain scale.(Change from baseline and 4-weeks prior to surgery or commencing 4-weeks of CSMT.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr. Paul Bishop

Clinical Associate Professor, I.C.O.R.D. Research Professor, Division of Spine, Department of Orthopaedics, University of British Columbia

Vancouver General Hospital

研究点 (2)

Loading locations...

相似试验